Actinium

Actinium Pharmaceuticals is engaged in development and commercialization of immunotherapeutics for the treatment of cancer. Read more

Sandesh Seth's photo - Chairman & CEO of Actinium

Chairman & CEO

Sandesh Seth

CEO Approval Rating

74/100

Founded:

1997

Status:

PublicIndependent CompanyNYSEATNM

ACTINIUM TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Selecta Biosciences is the top competitor of Actinium. Selecta Biosciences is headquartered in Watertown, Massachusetts, and was founded in 2007. Selecta Biosciences competes in the Biotechnology field. Selecta Biosciences generates 2,527% the revenue of Actinium.

Tarveda is perceived as one of Actinium's biggest rivals. Tarveda was founded in Watertown, Massachusetts} in 2011. Like Actinium, Tarveda also operates in the Biotechnology industry. Compared to Actinium, Tarveda generates $8.3M more revenue.

CytomX is seen as one of Actinium's top competitors. CytomX is a Public company that was founded in South San Francisco, California in 2008. Like Actinium, CytomX also works within the Pharmaceuticals industry. CytomX has 116 more employees vs. Actinium.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is OncoResponse a competitor of Actinium?

Actinium Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$ < 1M

Actinium's revenue is the ranked 31th among it's top 10 competitors. The top 10 competitors average 77.5M. Over the last one quarters, Actinium's revenue has decreased by 0%. Specifically, in Q1 2021's revenue was $ < 1M.

Actinium Acquisitions

No recent acquisitions found related to Actinium

Actinium Funding History

Since Actinium was founded in 1997, it has participated in 1 round of funding. In total Actinium has raised $3.3M. Actinium's funding round was on Jan 2014 for a total of $3.3M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Jan 2014
$3.3M
-

Since Actinium was founded in 1997, it has participated in 1 round of funding. In total Actinium has raised $3.3M. Actinium's funding round was on Jan 2014 for a total of $3.3M

Actinium Investments

No recent investments found related to Actinium

Actinium News

June 3, 2021Benzinga

Actinium Activates Radiation Inside the Body for Target Conditioning of Cancer Cells

Actinium Pharmaceuticals Inc. (NYSE: ATNM), a clinical-stage biopharmaceutical company, is developing... See more »
March 31, 2021Virtual-Strategy Magazine

Actinium to Participate in the Cell & Gene Meeting on the Mediterranean

NEW YORK, March 31, 2021 /PRNewswire/ - Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actin... See more »
January 13, 2021FinanzNachrichten

Actinium Pharma Announces Research Collaboration With Astellas

TOKYO (dpa-AFX) - Actinium Pharmaceuticals, Inc. (ATNM) announced the research collaboration with Ast... See more »
December 30, 2020The Pharma Letter

Actinium Pharma cleared to proceed with lomab-B trial

USA-based biotech Actinium Pharmaceuticals saw its shares tank 22.5% to $8.31 by midday Tuesday, desp... See more »
December 29, 2020FinanzNachrichten

Actinium Says DMC Recommends Phase 3 SIERRA Trial Continue To Full Enrolment Of 150 Patients

WASHINGTON (dpa-AFX) - Actinium Pharmaceuticals, Inc. (ATNM) said Tuesday that the independent Data M... See more »

Actinium Press Releases

March 2, 2021PR Newswire

Actinium Announces Participation in H.C. Wainwright Global Life Sciences Conference

NEW YORK, March 2, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actini... See more »
February 11, 2021StreetInsider

Actinium Showcases Targeted Conditioning Program with 2 Oral Presentations Highlighting Iomab-B and Pivotal Phase 3 SIERRA Trial at 2021 Transplantation & Cellular Therapy Annual Meeting

NEW YORK, Feb. 11, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Acti... See more »
February 10, 2021PR Newswire

Actinium Announces Participation in BIO CEO & Investor Digital Conference

NEW YORK, Feb. 10, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actini... See more »
January 20, 2021centralcharts

Actinium to Participate in a Fireside Chat at the B. Riley Oncology Investor Conference

Actinium to Participate in a Fireside Chat at the B. Riley Oncology Investor Conference PR Newswire N... See more »
December 29, 2020PR Newswire

Actinium Announces Successful Pre-Planned Ad Hoc Interim Analysis of Phase 3 SIERRA trial

NEW YORK, Dec. 29, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actini... See more »
December 9, 2020PR Newswire

Actinium Highlights Presence at Targeted Radiopharmaceuticals Summit

NEW YORK, Dec. 9, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actiniu... See more »
December 7, 2020PR Newswire

Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 75% of Total Patient Enrollment at the 62nd American Society of Hematology Annual Meeting

NEW YORK, Dec. 7, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actiniu... See more »

Actinium Videos

February 8, 2016Actinium Pharmaceuticals Vimeo Channel

"May 2014 Long" on VIMEO

Cast: David Gould... See more »
February 8, 2016Actinium Pharmaceuticals Vimeo Channel

"May 2015 Highlights" on VIMEO

Cast: David Gould... See more »
February 8, 2016Actinium Pharmaceuticals Vimeo Channel

"ATTNM PPT" on VIMEO

Cast: David Gould... See more »

Social Media

Actinium Headquarters

275 Madison Avenue 7th Floor

New York, New York10016

646-459-4201

Driving Directions »

Trending Companies

Actinium Summary

ABOUT

Overview

Actinium Pharmaceuticals is engaged in development and commercialization of immunotherapeutics for the treatment of cancer. Actinium was founded in 1997. Actinium's headquarters is located in New York, New York, USA 10016. It has raised 3.3M in 1 roun...

CEO

Actinium's Chairman & CEO, Sandesh Seth, currently has an approval rating of 74%. Actinium's primary competitors are Selecta Biosciences, Tarveda & CytomX.

Frequently Asked Questions about Actinium

  1. When was Actinium founded?

    Actinium was founded in 1997
  2. Who is Actinium's CEO?

    Actinium's CEO is Sandesh Seth
  3. How much revenue does Actinium generate?

    Actinium generates $ < 1M in revenue
  4. How much funding does Actinium have?

    Actinium has historically raised $3.3M in funding
  1. Where is Actinium's headquarters?

    Actinium's headquarters is in New York New York, USA
  2. How many employees does Actinium have?

    Actinium has 30 employees
  3. What sector does Actinium operate in?

    Actinium is in Pharmaceuticals, Biotechnology
  4. Who are Actinium's competitors?

    Actinium's top competitors are Selecta Biosciences, Tarveda, CytomX